Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Signs Distribution Agreement for Quickstrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order

July 16, 2019


Burlington, ON, July 16, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Ukraine Pharma (the “Company”) announced today that they have signed a twelve month distribution  agreement (the “Agreement”) to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European...

Rapid Dose Therapeutics and Chemesis to Introduce Innovative Quickstrip™ Oral Thin Strips to the Michigan Cannabis Market

June 27, 2019


Burlington, ON and Vancouver, BC, June 27, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company”) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”) expanding the...

Rapid Dose Therapeutics Announces Commercialization of Quickstrip™ Oral Thin Strips

June 13, 2019


Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip™ across United States & Puerto Rico BURLINGTON, Ontario – June 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient...

Rapid Dose Therapeutics Appoints Vice President, Research & Innovation

June 6, 2019


BURLINGTON, Ontario – June 6, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions,  is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished...

Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

April 16, 2019


BURLINGTON, Ontario – April 16, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates...

Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update

April 10, 2019


BURLINGTON, Ontario – April 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effectively immediately. Mr. Fodie replaces Mr. Lino...

Rapid Dose Therapeutics and Thrive Cannabis Sign MOU to Provide Quickstrip™ Oral Thin Strips Under a White Label Manufacturing Agreement

March 13, 2019


BURLINGTON, Ontario – March 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding (“MOU”) February 27, 2019...

Rapid Dose Therapeutics Corp. Grants Stock Options

March 11, 2019


Burlington, Ontario – March 11, 2019– Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) announces the grant of options to directors, officers, employees and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or...

Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT’s Case is Dismissed.

March 5, 2019


BURLINGTON, Ontario – March 5, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT...

Rapid Dose Therapeutics Corp. Announces Amalgamation with its Wholly-Owned Subsidiary, Rapid Dose Therapeutics Inc.

March 4, 2019


Burlington, Ontario — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce the completion of a vertical amalgamation (the “Amalgamation”) with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation...

1 2 3